首页> 外文期刊>Open Journal of Obstetrics and Gynecology >Metastatic Ovarian Tumor of Vulvar Malignant Melanoma in a 43-Year-Old Woman: A Case Report and Literature Review
【24h】

Metastatic Ovarian Tumor of Vulvar Malignant Melanoma in a 43-Year-Old Woman: A Case Report and Literature Review

机译:一个43岁女性外阴恶性黑素瘤的转移性卵巢肿瘤:案例报告和文献综述

获取原文
           

摘要

An ovarian malignant melanoma sometimes occurs from ovarian teratoma. Ovarian metastatic malignant melanoma is extremely rare. We describe a patient in whom vulvar melanoma (previously resected) metastasized to the ovary, making ovarian metastatic malignant melanoma. A 43-year-old Japanese woman was referred to us because of left ovarian tumor. She had undergone resection for malignant melanoma on the right labia minora with inguinal lymph node metastasis (pT1bN1aM0, stage IIIA, FIGO 2008). Eighteen months after this surgery, CT scans revealed left ovarian tumor and swelled pelvic lymph nodes, with a pelvic examination disclosing a left adnexal solid mass, with normal serum CA125 level (21.7 U/mL). Laparotomy revealed a left solid ovarian tumor measuring 4 cm, which was covered with a smooth grayish capsule. The right ovary, uterus, and pelvic cavity appeared normal. Upon sectioning during the surgery, the cross-sectional surface of the left ovary revealed a dark brown solid tumor. Following an intra-operative frozen-section diagnosis as metastatic melanoma, total hysterectomy with bilateral salpingo-oophorectomy and pelvic lymph dissection was performed. Histological examination confirmed the diagnosis as malignant melanoma metastasis to the left ovary and the obturator lymph node: the same laterality (left) as the primary site. The tumor was entirely composed of malignant melanoma cells with no evidence of teratoma. Combined chemotherapy with dabrafenib mesylate and trametinib was planned based on the positive BRAF mutations. This case highlights the importance that physicians should have high index of suspicion for the occurrence of ovarian melanoma metastasis after melanoma surgery. We also made extensive literature review on this issue, of which description may contribute to better understanding of this condition.
机译:卵巢恶性黑色素瘤有时发生在卵巢畸胎瘤。卵巢转移性恶性黑色素瘤极少数。我们描述了一个患者,其中包括外阴黑色素瘤(以前切除)转移到卵巢,使卵巢转移性恶性黑色素瘤。由于左卵巢肿瘤,一名43岁的日本女性被提到了我们。她对右唇巨大的含有腹股沟淋巴结转移(PT1BN1AM0,IIIA,FIGO 2008)进行了对恶性黑色素瘤的切除切除。这次手术后十八个月,CT扫描显示左卵巢肿瘤和膨胀的盆腔淋巴结,用骨盆检查公开左侧旁边固体质量,具有正常的血清Ca125水平(21.7u / ml)。剖腹术揭示了4厘米的左固体卵巢肿瘤,用光滑的灰胶囊覆盖。右卵巢,子宫和骨盆腔出现正常。在手术期间切片时,左卵巢的横截面表面揭示了深棕色固体瘤。在术中术中的冻结部分诊断作为转移性黑色素瘤之后,进行双侧Salpingo-Oophorectomy和盆腔淋巴剖分的总子宫切除术。组织学检查证实了诊断作为恶性黑色素瘤转移到左卵巢和闭合剂淋巴结:作为主要部位的横向(左)相同。肿瘤完全由恶性黑素瘤细胞组成,没有畸胎瘤的证据。根据阳性BRAF突变计划与Dabrafenib甲磺酸盐和曲米米的组合化疗。这种情况突出了医生应在黑素瘤手术后发生卵巢黑素瘤转移的高度怀疑索引的重要性。我们还对此问题进行了广泛的文献综述,其中描述可能有助于更好地了解这种情况。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号